161
If they had not been diagnosed with spinal muscular atrophy (SMA) at the time of birth, perhaps today, two years later, Filippo and Sara would not be here. With these words, the presentation of a pilot project for the screening of newborns for this serious and rare disease, which affects young children and which is the leading cause of death from genetic diseases in childhood, opens with these words.
.